Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Drug:
ISIS 3521
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Paclitaxel and Carboplatin With Versus Without ISIS 3521 in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
ISIS-3521-CS17
, CWRU-040123, ISIS-1501, NCT00017407
2.
Phase II Study of ISIS 3521 in Patients with Refractory or Recurrent High Grade Astrocytomas
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NABTT-9706
, JHOC-NABTT-9706
3.
Phase II Randomized Study of ISIS 5132 or ISIS 3521 in Women With Previously Treated Metastatic Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
ECOG-3197
, NCT00003236, E3197
4.
Phase II Randomized Study of ISIS 3521 and ISIS 5132 in Patients with Hormone Refractory Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
CAN-NCIC-IND111
, IND111
5.
Phase II Randomized Study of ISIS 3521 and ISIS 5132 for Locally Advanced or Metastatic Colorectal Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
CAN-NCIC-IND112
, IND112
6.
Phase II Study of ISIS 3521 in Patients with Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer or Unresectable or Metastatic Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
EORTC-16977
, ISIS-EORTC-16977, NCT00003989
7.
Phase II Study of ISIS 3521 in Patients With Previously Treated, Low-Grade Non-Hodgkin's Lymphoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
UCLA-000808401
, ISIS-3521-CS18, NCI-G02-2056
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute